WASHINGTON, United States: (AFP) Pfizer said on Tuesday (Dec 14) that clinical trials confirmed its Covid-19 pill – a new type of treatment that should withstand the mutations seen with the Omicron variant – drastically reduced hospitalisations and deaths among at-risk people by almost 90%. Read full story



